Journal
VOX SANGUINIS
Volume 100, Issue 3, Pages 340-342Publisher
WILEY
DOI: 10.1111/j.1423-0410.2010.01412.x
Keywords
-
Categories
Funding
- NHS Blood and Transplant, UK
- Health Protection Agency, UK
Ask authors/readers for more resources
Background and Objective The risk of hepatitis E virus (HEV) to blood safety remains unknown in England. Reports of persistent HEV infection with serious disease sequelae indicate that transfusion transmitted HEV is not a trivial disease in immunosuppressed patients. Materials and Methods Samples from unselected blood donors and donors with a history of jaundice were tested for HEV antibody and RNA. Results Overall, 10% of the donor sera were anti-HEV IgG reactive. Four of the donor samples were anti-HEV IgM reactive but HEV RNA negative. Conclusion There is evidence of probable recent HEV infections in donors with a predicted attack rate of 2 center dot 8%.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available